Resources
Statement
AESGP Statement on the European Commission’s Communication “Save gas for a safe winter” (2022)
Position Paper
AESGP Reply to European Commission’s Regulation Proposal on the European Health Data Space (2022)
Statement
AESGP Statement on the MDCG Guidance on borderline between medical devices and medicinal products under Regulation (EU) 2017/745 on medical devices (MDCG 2022 – 5) (2022)
Study
AESGP Summary Report “Self-Care in Europe: Economic and Social Impact on Individuals and Society” (2021)
Position Paper
AESGP Reply to European Commission's Regulation Proposal on Artificial Intelligence (2021)
Position Paper
AESGP Evidence Summary: Self-care in times of pandemic and beyond: looking back a year after (2021)
Position Paper
AESGP Position Paper on Paving the way for the digitalisation of the self-care sector (2021)
Position Paper
AESGP Reply to European Commission’s Inception Impact Assessment on a European Health Emergency Preparedness and Response Authority - HERA (2021)
Position Paper
AESGP Position Paper on a reinforced EMA mandate - European Health Union (2021)
Statement
AESGP Reaction to European Commission’s Communication on the EU Pharmaceutical Strategy (2020)
Position Paper
AESGP Reply to European Commission’s Roadmap for the Pharmaceutical Strategy (2020)
Position Paper
AESGP Position Paper on Shortages of medicinal products for citizens in Europe (2020)
Statement